What is HEPA's dilution risk score?

HEPA has a latest available DilutionScore record of 41/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for HEPA, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for HEPA?

DilutionWatch tracks 25 SEC filing types for HEPA including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect HEPA shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For HEPA, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for HEPA tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for HEPA. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

HEPA Dilution Risk Score: 41/100 (component-limited)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

40

📊Float Risk—

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 27%

🔄 Reverse Split model est. 55%

• 50-day avg $0.06 below $1 exchange minimum

🔔 Track HEPA — Get forecast alerts →

Market Data

Market Cap$1.92M

Shares Outstanding90.22M

FloatN/A

Cash$13.92M

Debt$176.6K

Short InterestN/A

Institutional Holdings

1 institutional holders · 618 shares

#1 BARCLAYS PLC 618 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.5K

Days to Cover1.0

% of FloatN/A

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

xbrl XBRL WARRANT 2025-12-31

8-K 8K EVENT 2026-04-22

3 FORM3 2026-03-18

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual HEPA Dilution Snapshot

Hepion Pharmaceuticals, Inc. (HEPA) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 553,846.
Recent SEC activity tracked for HEPA: 8-K on 2026-04-22; 3 on 2026-03-18; 3 on 2026-03-18.
Score coverage note: Float Risk is excluded because public-float data is unavailable.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Float Risk is excluded because public-float data is unavailable.

HEPA — Hepion Pharmaceuticals, Inc. Dilution Risk Tracker